LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 84.92 | 771.67 | 1459 | 12266 | 0.1189 | 0.1731 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 84.92 | 771.67 | 1600 | 12266 | 0.1304 | 0.2005 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 87.14 | 771.67 | 1469 | 12592 | 0.1167 | 0.1733 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 87.14 | 771.67 | 1642 | 12592 | 0.1304 | 0.2062 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 2.49 | 771.67 | 811 | 867 | 0.9346 | 0.3413 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 2.49 | 771.67 | 987 | 867 | 1.1374 | 3.2791 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 4.71 | 771.67 | 886 | 956 | 0.9264 | 0.5625 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 4.71 | 771.67 | 1129 | 956 | 1.1805 | 2.4183 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 6.94 | 771.67 | 959 | 1045 | 0.9176 | 0.6432 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 6.94 | 771.67 | 1190 | 1045 | 1.1386 | 1.6907 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 9.16 | 771.67 | 1007 | 1138 | 0.8845 | 0.6071 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 9.16 | 771.67 | 1259 | 1138 | 1.1058 | 1.3928 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 11.56 | 771.67 | 1140 | 1280 | 0.8902 | 0.7057 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 11.56 | 771.67 | 1419 | 1280 | 1.1081 | 1.3015 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 13.78 | 771.67 | 1233 | 1459 | 0.8447 | 0.6646 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 13.78 | 771.67 | 1522 | 1459 | 1.0426 | 1.0929 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 16.00 | 771.67 | 1306 | 1585 | 0.8237 | 0.6594 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 16.00 | 771.67 | 1634 | 1585 | 1.0306 | 1.0589 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 18.22 | 771.67 | 1356 | 1741 | 0.7787 | 0.6163 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 18.22 | 771.67 | 1675 | 1741 | 0.9619 | 0.9349 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 20.44 | 771.67 | 1360 | 1910 | 0.7117 | 0.5422 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 20.44 | 771.67 | 1672 | 1910 | 0.8750 | 0.8059 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 22.66 | 771.67 | 1387 | 2141 | 0.6477 | 0.4891 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 22.66 | 771.67 | 1665 | 2141 | 0.7775 | 0.6858 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 24.89 | 771.67 | 1369 | 2397 | 0.5710 | 0.4198 | MN20160304_L01 | E15 |